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Abstract
Background: We examined the association between quality of care and 30 day mortality in a
nationwide cohort of patients hospitalized with hip fracture.
Methods: We used data from The Danish National Indicator Project, a quality improvement
initiative with participation of more than 90% of Danish hospital departments caring for patients
with hip fracture between August 16, 2005 and August 15, 2006. Quality of care was measured in
terms of meeting five specific criteria: early assessment of the patient's nutritional risk, systematic
pain assessment during mobilization, assessment of Activities of Daily Living (ADL) before the
fracture, assessment of ADL before discharge, and initiation of treatment to prevent future
osteoporotic fractures. The association between meeting each of the quality of care criteria for the
patient and 30 day mortality was examined using logistic regression to adjust for potential
confounders.
Results: 6,266 patients hospitalized with an incident episode of hip fracture were included in the
study. For four of the five quality of care criteria, patients who met the criterion had substantially
lower 30 day mortality after hip fracture. The adjusted mortality odds ratios (ORs) ranged from
0.42 (95% CI, 0.30 to 0.58) for assessment of ADL before discharge (excluding deaths during
hospitalization) to 0.72 (95% CI, 0.52 to 1.00) for systematic pain assessment. We found an inverse
dose-response relationship between the number of quality of care criteria met and 30 day
mortality; the lowest mortality was found among patients for whom all five quality of care criteria
were met, as compared with patients for whom no quality of care criteria were met: adjusted
mortality OR 0.18 (95% CI, 0.09 to 0.36).
Conclusion: Higher quality of care during hospitalization with hip fracture was associated with
lowered 30 day mortality.
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Background
Hip fracture is a major clinical and public health problem
and the one condition associated with the largest use of
bed days in hospitals in the Western World [1,2]. In Den-
mark there are approximately 9,500 annual hospital
admissions with hip fractures, corresponding to 1 episode
per 100 persons aged over 65 years per year [3]. Mortality
within 30 days after hospitalization with a hip fracture
ranges from 6% to 13% [1,4-10]. Moreover cohort studies
have demonstrated excess mortality in patients with hip
fracture compared with sex- and age-matched controls for
up to ten years after the fracture [10-13].
Several studies have used a before-after design to examine
the effect of implementation of treatment guidelines or
care pathways for hip fracture patients with inconsistent
results [14-21]. To our knowledge, only one cohort study
from the U.S. examined the effect of meeting specific proc-
esses of treatment and care on the prognosis for individual
patients. This study found that meeting a scale of proc-
esses of care for patients with hip fracture was associated
with improved functional outcomes after two months but
not after six months and not with mortality [22].
A recent nationwide Danish study among patients with
stroke found that meeting six individual quality of care
criteria was associated with lowered 30 and 90 day mor-
tality [23]. As prevalence of hip fracture increases in the
ageing Western populations [10,24], prevention of hip
fracture-related deaths has significant clinical and public
health importance. We examined the association between
quality of treatment and care defined as meeting five qual-
ity of care criteria and 30 day mortality among patients
with hip fracture in a nationwide population-based
cohort study.
Methods
The Danish National Indicator Project (DNIP)
The Danish National Health Service provides tax-sup-
ported health care for all inhabitants of Denmark, includ-
ing free access to hospital care. DNIP is a nationwide
initiative to document, monitor and improve the quality
of treatment and care provided by the Danish health care
system. The project started in 2000 and focuses on devel-
oping and implementing evidence-based indicators
related to health care structure, process, and outcomes
[23,25]. Hip fracture is one of eight specific diseases mon-
itored in the DNIP by clinical indicators and quality
standards. All patients ≥ 65 years admitted to Danish hos-
pitals with a hip fracture, i.e., medial, pertrochanteric or
subtrochanteric femur fracture are eligible for inclusion in
the DNIP database. All Danish hospital departments
(except from hospitals in the Copenhagen Hospital Cor-
poration) caring for patients with hip fracture participated
in the project during the study period. Thus a total of 28
hospitals (32 departments, more than 90% of all hospital
departments caring for patients with hip fractures)
reported data on hip fracture to DNIP in 2006. Each par-
ticipating hospital department in the DNIP receives on a
continuous basis their own results on the proportion of
their patients meeting a number of quality of care criteria
(see below). In the DNIP database, individual-level data
for hip fracture patients from all hospitals are stored,
including prospectively collected patient characteristics
and the type and number of quality of care criteria each
patient met during hospital stay.
Study population
We identified all patients with a hip fracture in the DNIP
database who had a discharge date between August 16,
2005 and August 15, 2006 (N = 6,456). We excluded
patients with multiple hip fractures during this study
period to include only the first recorded hip fracture (n =
6,336). We excluded a few patients (n = 4) whose admis-
sion date was erroneously recorded to be later than the
hip fracture operation or discharge date, and patients with
more than one year time span between hospital admis-
sion and discharge (n = 2). Finally, we excluded patients
with missing data for all five quality of care criteria (n =
64). Our study cohort thus comprised 6,266 patients with
incident hip fracture.
Quality of care criteria
A Danish national expert panel including physicians,
nurses, physiotherapists, and occupational therapists
identified five quality of care criteria to be measured dur-
ing hospitalization with a hip fracture. The choice of crite-
ria was based on a systematic search of the scientific
literature and considerations regarding the feasibility of
collecting the required data in routine clinical settings
[25]. The five specific criteria are: early assessment (within
2 days after admission) of the patient's nutritional risk,
systematic pain assessment during mobilization of the
patient, assessment of Activities of Daily Living (ADL)
before the fracture, assessment of ADL before discharge,
and initiation of treatment to prevent future osteoporotic
fractures. Assessment of nutritional risk was done accord-
ing to updated nationwide guidelines. Systematic pain
assessment had to be done using a pain scale with docu-
mented validity. Assessment of ADL before the fracture
and again before discharge had to be done using a specific
test to assess functional disability. Initiation of treatment
to prevent future osteoporotic fractures was defined as
ordination of any anti-osteoporotic medications or hip
protectors. For two criteria, systematic pain assessment
and prevention of future osteoporotic fractures, it was
possible to classify patients as non-eligible: for instance if
the patient had dementia or hemiplegia and therefore
could not state their level of pain during mobilization, orBMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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if the patient already received anti-osteoporotic medica-
tion or had contraindications for treatment.
During hospitalization, hospital staff collected data on if
the five quality of care criteria were met, as well as demo-
graphic characteristics and a range of prognostic covari-
ates for each patient using a standardized form. After
hospital discharge the computerized patient data were
entered into the nationwide central DNIP database by the
hospital staff.
Mortality
Information on mortality during the study's follow-up
period was obtained through linkage with the Danish
Civil Registration System, which since 1968 has main-
tained electronic records of changes in vital status and
migration for the entire Danish population [26].
Patient characteristics
At the time of hospital admission, data was collected on
the following patient characteristics: age, gender, living
situation (living together with another adult, living alone
in one's own home, or other including living in a nursing
home or other institution), alcohol intake (≤ 14/21 or
>14/21 drinks per week for women/men, respectively),
and smoking habits (current, former, never), respectively.
During the hospitalization, data was collected on the fol-
lowing disease-related covariates: type of fracture (medial,
pertrochanteric, subtrochanteric), fracture displacement
(displaced, undisplaced), delay before surgery (< 23
hours, 24-47 hours, 48-71 hours, and more than 72
hours), the American Society of Anaesthesiologists' (ASA)
classification score before surgery (healthy, mild systemic
disease, severe but not incapacitating systemic disease,
incapacitating and life-threatening systemic disease, or
moribund patient not expected to survive for 24 h), and
type of surgery (osteosynthesis, hemi alloplastic, total
alloplastic, other operation), respectively.
To adjust for the individual burden of comorbidity in our
mortality analyses, we computed Charlson comorbidity
index scores for all patients with hip fracture using records
of all hospital discharge diagnoses made prior to the
admission date in the Danish hospital discharge registry.
This registry was established in 1977 and collects data on
all hospitalizations, including dates of admission and dis-
charge, surgical procedure(s) performed, and up to 20 dis-
charge diagnoses assigned by the treating physician and
coded according to the International Classification of Dis-
eases (8th revision (ICD-8) until the end of 1993, and 10th
revision (ICD-10) thereafter).
The Charlson comorbidity [27] index covers 19 major dis-
ease categories, weighted according to their prognostic
impact on patient survival, and has been validated for use
with discharge registry data in the ICD databases for pre-
diction of mortality [28]. We defined three levels of
comorbidity for each patient, based on the complete hos-
pital discharge history since 1994, as follows: 'low' for
patients with no recorded underlying diseases included in
the Charlson index; 'medium' (score 1-2); and 'high'
(score >2).
The study was approved by The Danish Data Protection
Agency (record no. 2007-41-0073).
Statistical analysis
We used logistic regression to compute odds ratios (ORs)
with 95% confidence intervals (CIs) for mortality at day
30 after hip fracture according to type and number of
quality of care criteria met, adjusting for age, sex, the
patient's living situation, and the Charlson comorbidity
index score. In the second model we additionally adjusted
for acute disease-related variables, i.e., type of fracture,
fracture displacement status, ASA classification score,
delay before surgery, and type of surgery, respectively.
Because alcohol and smoking data was missing for 28.3%
and 29.1% of the patients, respectively, the full model was
run both with and without inclusion of alcohol and
smoking data.
In all adjusted analysis, we used a random effect model to
correct for possible clustering by hospital, because other
and unmeasured quality of care characteristics at the
health care provider level might be associated with patient
mortality [29].
We first examined the association between each individ-
ual quality of care criterion met and 30 day mortality.
Patients were excluded from the analysis if there was miss-
ing data if the specific quality of care criterion was met
(ranging from 0.4% of patients for assessment of nutri-
tional risk or ADL before the fracture to 15.4% for system-
atic pain assessment) or if the criterion was found non-
eligible to the patient (i.e. if the patient had contraindica-
tions). Thus, the number of patients included in the anal-
yses of the specific quality of care criteria differed. We ran
analyses both for the entire patient cohort with use of sep-
arate categories for missing data on prognostic character-
istics, and for a cohort of patients who had complete data
on all prognostic characteristics. We also examined
whether the quality of care criteria were independently
associated with 30 day mortality by including all of the
criteria into one model and thereby mutually adjusting
them. This analysis was only possible to do among
patients who were eligible for all quality of care criteria.
Secondly, we examined the association between the
number of quality of care criteria met and 30 day mortal-BMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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ity. For this analysis, we only included patients found eli-
gible for all quality of care criteria. In an alternative
model, we examined the association between the propor-
tion (0-20%, 21-40%, 41-60%, 61-80%, and 81-100%) of
all  relevant  quality of care criteria met and mortality
within 30 days, also including patients for whom one or
two criteria were found non-eligible.
Thirdly, we did a number of subanalyses to test the robust-
ness of our findings. To reduce confounding by contrain-
dication in patients near end-of-life we reran analyses
with exclusion of patients who died during hospitaliza-
tion. We also ran analyses for 30 day post-discharge mor-
tality among all patients discharged alive, and for 180
days of follow-up both post-admission and post-dis-
charge. All statistical analyses were performed with
STATA™ software (version 8.2).
Results
Table 1 shows demographic and clinical characteristics of
the 6,266 patients hospitalized with a hip fracture. The
median age was 83, and 74% of the study population
were women. Nearly one half of the patients were living
alone.
The quality of care criteria were met for 30% of patients
with respect to systematic pain assessment, for 35% of the
patients concerning assessment of nutrition risk, for 39%
of the patients concerning initiation of treatment to pre-
vent future osteoporotic fractures, for 66% of the patients
with respect to assessment of ADL before discharge, and
for 69% concerning assessment of ADL before the hip
fracture. The overall 30 day mortality in our cohort was
10.3%.
Table 2 presents crude and adjusted odds ratios (ORs) for
death within 30 days according to quality of care criteria
met. For four of the five quality of care criteria, patients
who met the criterion had substantially lower 30 day mor-
tality. Adjusted ORs for death in the full model ranged
from 0.28 (95% CI 0.21 to 0.37) for assessment of ADL
before discharge to 0.72 (95% CI 0.52 to 1.00) for system-
atic pain assessment during mobilization. For assessment
of the patient's nutritional risk 30 day mortality was not
reduced. The mortality estimates were not materially
influenced by the statistical model used (i.e., excluding
patients with missing data on prognostic characteristics or
separate categories for missing data these factors). When
we included all quality of care criteria in the same regres-
sion model for their mutual adjustment, systematic pain
assessment (adjusted OR 1.25, 95% CI 0.83 to 1.88) and
assessment of ADL before the fracture (adjusted OR 1.12,
95% CI 0.69 to 1.82) lost their independent association
with reduced mortality. Mutual adjustment had only a
minor impact on the other three criteria's association with
mortality, with the lowest adjusted ORs found for assess-
ment of ADL before discharge (OR 0.21, 95% CI 0.15 to
0.30) and prevention of future osteoporotic fractures (OR
0.57, 95% CI 0.38 to 0.85).
Table 3 shows adjusted ORs for 30 day mortality by
number of quality of care criteria met among patients who
were eligible for all the quality of care criteria. We found
an inverse dose-response relationship between the
number of quality of care criteria met and 30 day mortal-
ity. The lowest 30 day mortality was found among
patients for whom all five quality of care criteria were met,
compared to patients for whom no quality of care criteria
were met: adjusted mortality OR 0.18 (95% CI 0.09 to
0.36) (Table 3). A similar trend was found when analyses
were done for the proportion of relevant quality of care
criteria met: Using 0-20% of criteria met as the reference
category, adjusted ORs were 1.00 (0.63-1.57), 0.45 (0.27-
0.73, 0.46 (0.28-0.75) and 0.28 (0.18-0.44) for 21-40%,
41-60%, 61-80%, and 81-100% of criteria met, respec-
tively.
Table 4 shows adjusted mortality ORs for fulfillment of
each quality of care criteria according to different sensitiv-
ity analyses and follow-up periods up till 180 days after
discharge. When we included only the 5,948 patients who
were alive at discharge in the analyses (318 patients who
died during hospitalization excluded) the association
between quality of care and 30 day post-admission mor-
tality weakened but remained statistically significant
(Table 4). When we analyzed 30 day post-discharge mor-
tality among all patients discharged alive we found further
weakened associations, but for four quality of care criteria,
patients who met the criterion still had lower mortality
with adjusted ORs between 0.55 and 0.80. Similar mortal-
ity associations were found for 180 days of follow-up
post-admission or post-discharge (Table 4). Finally, when
we reran 30-day mortality analyses separately for the three
largest hospitals caring for hip fracture patients in Den-
mark, we found associations between meeting each of the
quality of care criteria and lower mortality that were qual-
itatively similar to the associations found on the nation-
wide level.
Discussion
We found that a higher quality of care offered to patients
with a hip fracture, defined as meeting specific quality of
care criteria, was associated with substantially lower 30
day mortality for most criteria met. The association
remained robust after adjusting for a range of possible
confounding factors and in several sensitivity analyses
done. We also found that the association between the
number of quality of care criteria met and 30 day mortal-
ity appeared to follow an inverse dose-response pattern.BMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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The strengths of our study are its size, the nationwide pop-
ulation-based design, the complete follow-up for ascer-
tainment of survival status, and our ability to adjust for a
wide range of potential confounders through access to
independent medical databases providing a complete
medical history.
Study limitations include the use of possibly inaccurate
data collected during routine clinical work in a large
number of settings. However, participation in DNIP is
mandatory for all departments in Denmark treating
patients a hip fracture and extensive efforts are made to
ensure the validity of DNIP data [25]. Thus a structured
audit process is carried out regularly on a national,
regional, and local basis to assess critically the quality of
the dataset and results. To ensure completeness of patient
registration in DNIP, its enrollees are compared with local
hospital discharge registries.
Table 1: Descriptive characteristics of 6266 patients with hip fracture registered in the Danish National Indicator Project.
Characteristic N (%)
Age, years* 83.2 (65.0-107.8)
Gender:
- Women 4626 (73.8%)
- Men 1640 (26.2%)
Living situation:
- Living with someone 1636 (26.1%)
- Living alone 3176 (50.7%)
- Other 1025 (16.4%)
- Missing data 429 (6.9%)
Alcohol intake†:
- < 14/21 drinks per week 4305 (68.7%)
- > 14/21 drinks per week 186 (2.9%)
- Missing data 1775 (28.3%)
Smoking habits:
- Current smoker 1329 (21.2%)
- Former smoker 980 (15.6%)
- Never smoked 2133 (34.0%)
- Missing data 1824 (29.1%)
Type of fracture:
- Medial 3187 (50.9%)
- Pertrochanteric 2564 (40.9%)
- Subtrochanteric 392 (6.3%)
- Unknown 123 (2,0%)
Fracture displacement:
- Displaced 4598 (73.4%)
- Undisplaced 907 (14.5%)
- Unknown 761 (12.1%)
Delay before surgery, days*: 1 (0-124)
Type of surgery:
- Osteosynthesis 4493 (71.7%)
- Hemi alloplastic 1320 (21.1%)
- Total alloplastic 218 (3.5%)
- Other operation 28 (0.5%)
- Unknown 207 (3.3%)
ASA-score:
- Class 1: Healthy 584 (9.3%)
- Class 2: Mild systemic disease 2916 (46.5%)
- Class 3: Severe systemic disease not incapacitating 2042 (32.6%)
- Class 4: Incapacitating life-threatening systemic disease 324 (5.2%)
- Class 5: Moribund patient not expected to survive for 24 h 9 (0.1%)
Missing data 391 (6.2%)
Charlson comorbidity index score:
- 0 points 2442 (39.0%)
- 1-2 points 2584 (41.2%)
- 3+ points 1240 (19.8%)
August 16, 2005 - August 15, 2006.
* Age and operation delay are stated as median (minimum-maximum)
† Drinks per week for women/men, respectivelyBMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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Patients who were classified as non-eligible or with miss-
ing data for the respective quality of care criteria examined
had to be excluded in our study. Moreover, some patients
had missing data for prognostic characteristics, but in gen-
eral the association found when excluding those with
missing data did not differ considerably from that based
on separate prognostic categories for missing data, which
indicates that the results are robust and reliable.
Importantly, our results may have been influenced by
confounding by contraindication, e.g., the staff may have
been less likely to offer early and appropriate care for frail
patients near end-of-life with poor baseline survival
chance. However, we were able to adjust for a wide range
of individual prognostic predictors, including both the
patients' entire medical history via the Charlson index
score and the surgeon's or anesthesiologist's acute evalua-
tion of the patient's baseline risk of death via the ASA
score. Furthermore, the staff had the possibility to con-
sider patients ineligible for several of the care processes,
for example, if a patient was found too weak to participate
in mobilization or systematic pain assessment. These
patients were subsequently excluded from our analysis of
the quality criterion. On this basis, it does not appear very
likely that the staff would deliberately withhold care to
patients with a severe prognosis whom they had consid-
Table 2: Relationship between quality of care criteria and 30 day mortality after admission with hip fracture.
Criteria met Proportion of patients who died
N (%)
Crude OR
(95% CI)
Adjusted OR*
(95% CI)
Model 1
Adjusted OR†
(95% CI)
Model 2
Assessment of nutritional risk within 2 days after admission
Yes 199/2204 (9.3) 0.82 (0.69 to 0.98) 0.93 (0.75 to 1.14) 0.98 (0.77 to 1.19)
No 434/4036 (10.8) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Systematic pain assessment during mobilization
Yes 107/1886 (5.7) 0.58 (0.46 to 0.74) 0.66 (0.47 to 0.92) 0.72 (0.52 to 1.00)
No 228/2440 (9.3) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Assessment of ADL before the fracture
Yes 331/4360 (7.6) 0.43 (0.36 to 0.51) 0.47 (0.33 to 0.66) 0.54 (0.39 to 0.76)
No 302/1881 (16.0) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Assessment of ADL before discharge
Yes 227/4122 (5.5) 0.25 (0.21 to 0.30) 0.27 (0.20 to 0.36) 0.28 (0.21 to 0.37)
No 400/2107 (19.0) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Initiation of treatment to prevent future osteoporotic fractures
Yes 157/2434 (6.5) 0.58 (0.47 to 0.71) 0.66 (0.49 to 0.88) 0.64 (0.48 to 0.85)
No 293/2742 (10.7) 1.00 (reference) 1.00 (reference) 1.00 (reference)
* Adjusted for age, gender, comorbidity and living situation.
† Adjusted for age, gender, comorbidity, living situation, type of fracture, fracture displacement status, ASA-score, delay until surgery and type of 
surgery.
Table 3: Relationship between number of quality of care criteria met and 30 day mortality.
Number of quality of care criteria met Proportion of patients who died
N (%)
Crude OR
(95% CI)
Adjusted OR*
(95% CI)
Model 1
Adjusted OR†
(95% CI)
Model 2
0 73/370 (19.7) 1.00
(reference)
1.00
(reference)
1.00
(reference)
1 36/362 (9.9) 0.45
(0.29 to 0.69)
0.55
(0.33 to 0.90)
0.68
(0.41 to 1.12)
2 54/811 (6.7) 0.29
(0,20 to 0.42)
0.31
(0.19 to 0.50)
0.34
(0.20 to 0.57)
3 40/812 (4.9) 0.21
(0.14 to 0.32)
0.25
(0.15 to 0.41)
0.30
(0.18 to 0.52)
4 22/819 (2.7) 0.11
(0.07 to 0.18)
0.13
(0.07 to 0.24)
0.17
(0.10 to 0.29)
5 16/510 (3.1) 0.13
(0.08 to 0.23)
0.17
(0.08 to 0.34)
0.18
(0.09 to 0.36)
Risk estimates calculated among hip fracture patients eligible for all quality of care criteria.
* Adjusted for age, gender, comorbidity and living situation.
† Adjusted for age, gender, comorbidity, living situation, type of fracture, fracture displacement status, ASA-score, delay until surgery and type of 
surgery.BMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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ered eligible to the specific care processes. Even excluding
all patients who died during hospitalization did not elim-
inate the association between quality of care and 30 day
post-admission mortality. Slightly weaker but consistent
associations were also observed for post-discharge mortal-
ity follow-up at both 30 and 180 days. Thus, we find it
unlikely that unmeasured or unknown confounders could
explain mortality decreases of the magnitude observed.
There are also some limitations with regard to selection
and definition of the quality of care criteria in the DNIP.
The criteria were deliberately selected to primarily reflect
the quality of care in the early phase of a hip fracture as in-
hospital care is the focus of DNIP. A range of other proc-
esses of care, including long-term rehabilitation which is
typically undertaken by other parts of the health care sys-
tem including the municipalities, are also highly relevant
for patients with hip fracture and the association between
the quality of such processes and mortality remains to be
clarified.
Most of the quality of care criteria used in DNIP hip frac-
ture are proxy measures for processes believed to influ-
ence the prognosis and mortality among patients with hip
fracture. For example, assessment of Activities of Daily
Living (ADL) before the fracture and again before dis-
charge cannot per se reduce mortality; however, assess-
ment may promote adequate mobilization and
rehabilitation, eventually leading to an improved progno-
sis. Poor nutritional status is associated with increased
length of stay [30] and mortality [31] following hip frac-
ture, and supplementary food intake may decrease mor-
tality [31]. Assessment of the patient's nutritional risk
forms the basis for nutritional therapy. There is similarly
good evidence that undertreated postoperative pain con-
tributes to increased length of stay and enhanced recovery
following hip fracture [32-34]. Systematic pain assess-
ment may promote improved pain control [34]. Finally,
there is increased risk of early subsequent fracture after a
first hip fracture [35]. Anti-osteoporotic treatment such as
calcium and vitamin D supplementation may decrease
future hip fracture risk [36] and be associated with other
Table 4: Relationship between quality of care criteria and mortality in different sensitivity analyses.
Adjusted * 
mortality OR (95% 
CI) for fulfilment of 
the quality of care 
criteria
Assessment of 
nutritional risk 
within 2 days after 
admission
Systematic pain 
assessment during 
mobilization
Assessment of 
ADL before the 
fracture
Assessment of 
ADL before 
discharge
Initiation of 
treatment to 
prevent future 
osteoporotic 
fractures
30-day post-
admission 
mortality
0.98
(0.77 to 1.19)
0.72
(0.52 to 1.00)
0.54
(0.39 to 0.76)
0.28
(0.21 to 0.37)
0.64
(0.48 to 0.85)
30-day post-
admission 
mortality excluding 
patients who died 
during 
hospitalization
1.01
(0.76 to 1.34)
0.73
(0.54 to 0.99)
0.65
(0.49 to 0.87)
0.42
(0.30 to 0.58)
0.73
(0.54 to 0.99)
30-day post-
discharge mortality
0.98
(0.78 to 1.22)
0.80
(0.64 to 1.02)
0.71
(0.53 to 0.94)
0.55
(0.41 to 0.73)
0.80
(0.63 to 1.01)
180-day post-
admission 
mortality
0.92
(0.78 to 1.10)
0.79
(0.63 to 0.99)
0.67
(0.53 to 0.85)
0.46
(0.37 to 0.58)
0.75
(0.61 to 0.91)
180-day post-
discharge mortality
0.93
(0.76 to 1.12)
0.79
(0.65 to 0.96)
0.76
(0.61 to 0.94)
0.61
(0.49 to 0.76)
0.81
(0.67 to 0.97)
30-day post-
admission 
mortality, largest 
hospital
0.38
(0.14 to 1.14)
0.22
(0.02 to 2.27)
0.50
(0.18 to 1.37)
0.50
(0.18 to 1.44)
0.40
(0.14 to 1.14)
30-day post-
admission 
mortality, second 
largest hospital
0.69
(0.23 to 2.05)
NA† 0.03
(0.01 to 0.15)
0.03
(0.01 to 0.15)
NA†
30-day post-
admission 
mortality, third 
largest hospital
0.97
(0.51 to 1.83)
0.78
(0.33 to 1.81)
0.60
(0.19 to 1.84)
0.18
(0.09 to 0.37)
0.72
(0.36 to 1.43)
* Adjusted for age, gender, comorbidity, living situation, type of fracture, fracture displacement status, ASA-score, delay until surgery and type of 
surgery. For post-discharge mortality ORs, also adjusted for length of hospital stay.
† No deaths among patients with systematic pain assessment or initiation of treatment to prevent future osteoporotic fractures.BMC Health Services Research 2009, 9:186 http://www.biomedcentral.com/1472-6963/9/186
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beneficial outcomes such as decreased risk of infection
[37].
Finally, we focused on mortality as the outcome in this
analysis. Despite its obvious importance, mortality is cer-
tainly not the only relevant end-point for patients with
hip fracture. Examination of association between quality
of care and other end-points, e.g., functional level after
discharge would of course also be highly relevant. Unfor-
tunately, data on functional level were not available in our
study.
It is difficult to compare our study with previous research,
because to our knowledge no prior studies have examined
the association between meeting the specific processes of
care used in our study and 30 day mortality. Most previ-
ous before-and-after studies examined the effects of
implementation of specific sets of guidelines or care path-
ways rather than the effect of meeting specific individual
processes of treatment and care. The only study [22] that
examined the effect of meeting processes of treatment and
care in hip fracture found that individual processes of
treatment and care were not associated with functional
outcomes or mortality after adjustment for potential con-
founding variables. However, the study found that meet-
ing the whole scale of processes of care was associated
with fewer readmissions and better locomotion, self-care,
and transferring (from for example the bed or toilet) at
two months but not at six months. Meeting the whole
scale of processes of care was not associated with mortality
at 6 months (Mortality Hazard Ratio = 0.95, P-value >
0.5), whereas the authors did not examine mortality after
30 days as in our study.
Conclusion
In conclusion, our large nationwide population-based
cohort study found that high quality of treatment and care
offered to patients with a hip fracture, defined by meeting
specific quality of care criteria, was associated with sub-
stantially lowered 30 day mortality. The association
between the number of quality of care criteria met and 30
day mortality appeared to follow an inverse dose-
response pattern. These findings indicate that it is possible
to link process and outcome and thereby provide direct
support for implementation of evidence-based treatment
and care to patients with hip fracture.
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